Introduction: Typically chemotherapy has been used as standard treatment and surgeries were rarely performed for recurrent extrahepatic biliary carcinoma (RBC). Thus whether surgery for RBC is feasible has remained unclear. Methods: From 2013 to 2019, 5 patients underwent radical resection for RBC at our institution. We retrospectively reviewed the medical data. Results: Recurrence sites were liver metastasis in 3 patients (LM group) and local or bile duct recurrence in 2 patients (BD group). In the LM group, the underlying pathology was distal bile duct carcinoma, gallbladder carcinoma and ampullary carcinoma. Limited resections of the liver were performed for all 3 patients in the LM group. There was no morbidity nor mortality. 1 patient with liver metastasis of gallbladder carcinoma survived 6 years after surgery for RBC. The other 2 patients had recurrence at 9 and 14 months after surgery. In the BD group, the underlying pathology was distal bile duct carcinoma and proximal bile duct carcinoma. 1 patient underwent pancreaticoduodenectomy in the primary surgery and extended right hemihepatectomy for RBC. The other underwent central bisegmentectomy of the liver in the primary surgery and right lateral sectionectomy of the liver for RBC. There was morbidity in 1 patient but no mortality. Both patients could achieve curative resection and survive without recurrence for 9 and 2 months after surgery for RBC. Conclusion: Surgery for RBC is technically demanding procedure but appears feasible and have a possibility of offering longer survival for selected patients but we should be cautious of indication.